Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leverger

Showing results (281-290 of 434) with videos related to

Pageof 44
Sort By:
Blood Advances|August 9, 2020
In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failureMathieu Simonin, Anne Auperin, Yves Bertrand, et al.
Cancer Causes & Control : CCC|July 12, 2008
Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE)Jérémie Rudant, Florence Menegaux, Guy Leverger, et al.
Environmental Health Perspectives|December 19, 2007
Household exposure to pesticides and risk of childhood hematopoietic malignancies: The ESCALE study (SFCE)Jérémie Rudant, Florence Menegaux, Guy Leverger, et al.
International Journal of Cancer|March 3, 2007
Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: the ESCALE study (SFCE)Jérémie Rudant, Florence Menegaux, Guy Leverger, et al.
Occupational and Environmental Medicine|February 14, 2009
Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE)P Brosselin, J Rudant, L Orsi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 15, 2015
Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in childrenAdam de Beaumais Tiphaine, Lisa Lynqsie Hjalgrim, Jacob Nersting, et al.
Leukemia & Lymphoma|April 10, 2015
Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21)Nicolas Duployez, Jean-Baptiste Micol, Nicolas Boissel, et al.
Blood|June 9, 2012
MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterationsIléana Antony-Debré, Dominique Bluteau, Raphael Itzykson, et al.
Leukemia|April 7, 2006
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)N Boissel, H Leroy, B Brethon, et al.
International Journal of Cancer|June 26, 2016
Risk of neuroblastoma, birth-related characteristics, congenital malformations and perinatal exposures: A pooled analysis of the ESCALE and ESTELLE French studies (SFCE)Paula Rios, Helen D Bailey, Laurent Orsi, et al.
Pageof 44

Showing results (281-290 of 434) with videos related to

Sort By:
Pageof 44
Blood Advances|August 9, 2020
In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failureMathieu Simonin, Anne Auperin, Yves Bertrand, et al.
Cancer Causes & Control : CCC|July 12, 2008
Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE)Jérémie Rudant, Florence Menegaux, Guy Leverger, et al.
Environmental Health Perspectives|December 19, 2007
Household exposure to pesticides and risk of childhood hematopoietic malignancies: The ESCALE study (SFCE)Jérémie Rudant, Florence Menegaux, Guy Leverger, et al.
International Journal of Cancer|March 3, 2007
Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: the ESCALE study (SFCE)Jérémie Rudant, Florence Menegaux, Guy Leverger, et al.
Occupational and Environmental Medicine|February 14, 2009
Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE)P Brosselin, J Rudant, L Orsi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 15, 2015
Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in childrenAdam de Beaumais Tiphaine, Lisa Lynqsie Hjalgrim, Jacob Nersting, et al.
Leukemia & Lymphoma|April 10, 2015
Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21)Nicolas Duployez, Jean-Baptiste Micol, Nicolas Boissel, et al.
Blood|June 9, 2012
MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterationsIléana Antony-Debré, Dominique Bluteau, Raphael Itzykson, et al.
Leukemia|April 7, 2006
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)N Boissel, H Leroy, B Brethon, et al.
International Journal of Cancer|June 26, 2016
Risk of neuroblastoma, birth-related characteristics, congenital malformations and perinatal exposures: A pooled analysis of the ESCALE and ESTELLE French studies (SFCE)Paula Rios, Helen D Bailey, Laurent Orsi, et al.
Pageof 44